Business
Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders
Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medications to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it adjourned, without conducting any business, the 2025 annual meeting of stockholders (the "Annual Meeting") on Tuesday, June 24, 2025, due to the fact that a quorum was not achieved and to allow more opportunity for Company stockholders to vote on all proposal
About this update from Rein Therapeutics, Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"Meeting adjourned to Wednesday, July 23, 2025 at 9:00 a.m. Eastern Time","length":71,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":71,"olType":false},{"type":"text","content":"AUSTIN, Texas, June 24, 2025 /PRNewswire/ -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medications to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it adjourned, without conducting any business, the 2025 annual meeting of stockholders (the "Annual Meeting") on Tuesday, June 24, 2025, due to the fact that a quorum was not achieved and to allow more opportunity for Company stockholders to vote on all proposals described in Rein's definitive proxy statement filed with the Securities and Exchange Commission (the "SEC") on May 12, 2025.","length":706,"tagName":"p"},{"type":"image","alt":"Rein Logo (PRNewsfoto/Rein Therapeutics, Inc.)","displaySize":"","headline":null,"caption":"Rein Logo (PRNewsfoto/Rein Therapeutics, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":226,"url":"https://media.zenfs.com/en/prnewswire.com/21d12d0173749cab9897840a84c884b9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lUNLcp9yz5L5abyqs4rZrg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/21d12d0173749cab9897840a84c884b9","width":400,"height":226}},"href":"https://mma.prnewswire.com/media/2595086/Rein_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Annual Meeting will reconvene on Wednesday, July 23, 2025, beginning at 9:00 a.m. Eastern Time at www.meetnow.global/M4RTYCN. The record date for the Annual Meeting continues to be the close of business on May 5, 2025. No changes have been made to the proposals to be voted on by stockholders at the Annual Meeting. The proxy statement is available at https://www.sec.gov/ and at www.envisionreports.com/RNTX. ","length":413,"tagName":"p"},{"type":"text","content":"Rein encourages all stockholders of record at the close of business on May 5, 2025 who have not yet voted, to vote by 11:59 p.m. Eastern Time on July 22, 2025.","length":159,"tagName":"p"},{"type":"text","content":"Rein's board of directors st...